July 19, 2008Stryker stock declines after warnings - Detroit Free Press Stryker stock declines after warnings - Detroit Free Press
Shares fell $2.96, or 4.3%, to close at $65.45 on the New York Stock Exchange. Stryker stock has lost 12.4% this year. The Food and Drug Administration has issued three warning letters to Stryker alleging manufacturing deficiencies at three plants. Source: www.freep.com Family sues co. for muscular dystrophy drug - NWITimes.com WASHINGTON - A Minnesota family is trying to force a New Jersey drug company to give their son an experimental drug for a fatal form of muscular dystrophy, saying he'll die without it. The boy's mother, Cheri Gunvalson, who helped persuade Congress Source: nwitimes.com Tomato scare squishes producers - United Press International SALINAS, Calif., July 19 (UPI) -- A recent salmonella outbreak has hit California tomato growers hard, with sales plummeting, experts say. Growers say by the time the U.S. Food and Drug Administration cleared tomatoes Thursday in its investigation of Source: www.upi.com Critics question FDA, U.S. Customs handling of Ranbaxy case - Newark Star-Ledger For two and a half years, the Food and Drug Administration collected evidence that Ranbaxy Laboratories, India's largest generic drugmaker, may have lied about the quality of medicines and chemicals it sent to the U.S. Regulators inspected Ranbaxy Source: www.nj.com Medivation drug improves Alzheimer's symptoms - CNN Money NEW YORK (Associated Press) - Biotechnology company Medivation Inc. said Thursday that Alzheimer's disease patient's taking the experimental drug Dimebon showed a significant improvement after six months and continued to benefit from the drug up to a Source: money.cnn.com # posted by Network @ 4:01 PM
 |
Subscribe to Posts [Atom]